| |
| HCC |Abstract Library |
 |
| |
| The summaries are free for public
use. The Chronic Liver Disease
Foundation will continue to add and
archive summaries of articles deemed
relevant to CLDF by the Board of
Trustees and its Advisors. |
| Abstract Details |
 |
|
| |
| |
| |
|
|
| |
Hepatocellular carcinoma: a clinical and pathological overview |
|
|
|
|
| |
Pathologica. 2021 Jun;113(3):203-217. doi: 10.32074/1591-951X-295.
Salvatore Lorenzo Renne 1 2, Samantha Sarcognato 3 4, Diana Sacchi 3, Maria Guido 3 4, Massimo Roncalli 1 2, Luigi Terracciano 1 2, Luca Di Tommaso 1 2
|
| |
|
|
| |
Author information
- 1Department of Biomedical Sciences, Humanitas University, Milan, Italy.
- 2IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy.
- 3Department of Pathology, Azienda ULSS2 Marca Trevigiana, Treviso, Italy.
- 4Department of Medicine - DIMED, University of Padova, Padova, Italy.
Abstract
HCC incidence rates have been rising in the past 3 decades and by 2025 > 1 million individuals will be affected annually. High-throughput sequencing technologies led to the identification of several molecular HCC subclasses that can be broadly grouped into 2 major subgroups, each characterized by specific morphological and phenotypical features. It is likely that this increasing knowledge and a more appropriate characterization of HCC at the pathological level will impact HCC patient management.
|
|
|
|
| |
| |
|
| |
|
|
|
|
|
